In vitro and in vivo studies on HPMC-K-100 M matrices containing naproxen sodium

Drug Delivery

Volumn 14, Issue 3, 2007, Pages 163-169

  Kumar, S Mahesh ^a   Chandrasekar, M J N ^a   Gopinath, R ^a   Srinivasan, R ^a   Nanjan, M J ^a   Suresh, B ^a  

^a JSS COLLEGE OF PHARMACY   (India)

Author keywords

Bioavailability; Controlled Release; Hydrophilic Matrices; Naproxen Sodium

Indexed keywords

FILLER; HYDROXYPROPYLMETHYLCELLULOSE; NAPROXEN; POLYMER;

ADULT; ARTICLE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DOSAGE FORM COMPARISON; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG RELEASE; DRUG STABILITY; HUMAN; HUMAN EXPERIMENT; HYDROPHILICITY; IN VITRO STUDY; IN VIVO STUDY; MALE; MATRIX TABLET; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL AVAILABILITY; CROSS-OVER STUDIES; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; DRUG COMPOUNDING; DRUG STABILITY; EXCIPIENTS; HARDNESS; HUMANS; HYDROGEN-ION CONCENTRATION; KINETICS; MALE; METHYLCELLULOSE; NAPROXEN; PYRROLIDINONES;

EID: 34247522293     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540601098682     Document Type: Article

References (22)

1. Amaral, H. M., Lobo, J. M. S., and Ferreira, D. C. 2001. Effect of hydroxypropyl methylcellulose and hydrogenated castor oil on naproxen release from sustained release tablets. AAPS Pharm. Sci. Tech. 2(2): article 6.
2. Alderman, D. A. 1984. A review of cellulose ethers in hydrophilic matrices for oral controlled-release dosage forms. Int. J. Pharm. Tech. Prod. Man. 5: 1-9.
3. Aulton, M. E., and Wells, T. I. 1988. Pharmaceutics: The Science of Dosage Form Design. 247-248. London: Churchill Livingstone.
4. Banker, G. S., and Anderson, N. R. 1987. Tablets. In The Theory and Practice of Industrial Pharmacy, ed. Lachman, L., Liberman, A. H., and Kanig, J. L., 297-321. Mumbai: Varghese Publishers.
5. Cardinal, J. R. 1984. Matrix systems. In Medical Applications of Controlled Release: Classes of Systems. ed. Langer, R. S., and Wise, D. L., 41-67. Boca Raton: CRC Press.
6. Cooper, J., and Gunn, C. 1986. Powder flow and compaction. In Tutorial Pharmacy, ed. Carter, S. J., 211-233. New Delhi: CBS Publishers and Distributors.
7. Costa, P., and Lobo, S. M. J. 2001. Modeling and comparison of dissolution profiles. Eur. J. Pharm. Sci. 13:123-133.
8. Cox, P. J. 1999. Development and evaluation of multiple-unit oral sustained release dosage forms for s (+)-ibuprofen: preparation and release kinetics. Int. J. Pharm. 193(1):73-84.
9. DeHaan, P., and Lerk, C. F. 1984. Oral controlled release dosage forms: a review. Pharm. Weekbl. Sci. Ed. 6:57-67.
10. Higuchi, T. 1963. Mechanism of sustained action medication: theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J. Pharm. Sci. 52(12):1145-1149.
11. Kiortsis, K., Kachrimanis, K., Broussali, T. H., and Malamataris, S. 2005. Drug release from tabletted wet granulations comprising cellulosic (HPMC or HPC) and hydrophobic component. Eur. J. Pharm. Biopharm. 39(5):73-83.
12. Li, V. H. K., and Lee, V. H. L. 1987. Influence of drug properties and routes of drug administration on the design of sustained and controlled release systems. In Controlled Drug Delivery: Fundamentals and Applications, ed. Robinson, J. R., and Lee, V. H. L., 3-94. New York: Marcel Dekker.
13. Lu, X. E., Qiang, Z., Zhang, Z. O., and Jiang, X. G. 2003. A water-soluble drug monolithic osmotic tablet system utilizing gum Arabic as an osmotic, suspending and expanding agent. J. Control. Rel. 92:375-382.
14. Melia, C. D. 1994. Hydrophilic matrix sustained release systems based on polysaccharide carriers. Crit. Rev. Ther. Drug Carrier Syst. 8:395-421.
15. Ozguney, I., Ertan, G., and Guneri, T. 2004. Dissolution characteristics of megaloporous tablets prepared with two kinds of matrix granules. II Farmaco. 599:549-555.
16. Peppas, N. A. 1985. Analysis of Fickian and non-Fickian drug release from polymers. Pharm. Acta Helv. 60:110-111.
17. Pharmacopoeia of India. 1996. New Delhi: Controller of Publications, Ministry of Health and Family Welfare.
18. Rekhi, G. S., Nellore, V. R., Hussain, S. A., Tillman, G. L., and Augsburger, L. L. 1998. Development of metoprolol tartrate extended release matrix tablet formulation for regulatory police consideration. J. Control. Rel. 50:247-256.
19. Salsa, T., Veiga, F., and Pina, M. E. 1997. Oral controlled-release dosage forms. I. Cellulose ether polymers in hydrophilic matrices. Drug Dev. Ind. Pharm. 23:929-938.
20. Todd, P. A., and Clissold, S. P. 1990. Naproxen: a reappraisal of its pharmacology and use in rheumatic diseases and pain states. Drugs 40:91-137.
21. United States Pharmacopoeia-24/National Formulary-19, 2000. Asian ed. Rockville, MD: USP Convention, 1149-1150.
22. Zecchi, V., Rodriguez, L., Tartarini, A., Chiarini, A., and Valenti, P. 1984. In vitro absorption studies on naproxen and its sodium and piperazine salts. Pharm. Acta Helv. 59:91-94.